Company: RPTX
Filing Date: 2025-12-03
Form Type: PREM14A
Source: 0001193125-25-306948
Chunk: 265

Company: Repare Therapeutics Inc.
Filing Date: 2025-12-03
Form: PREM14A
Chunk 265
---
 or would reasonably be expected to constitute or lead to a Superior Proposal; |

| (ii) | such person was not restricted from making such Acquisition Proposal pursuant to an existing confidentiality, 
 standstill or similar restriction;                                                                            |

| (iii) | the Company has been, and continues to be, in compliance with its obligations under this Article 6; |

| (iv) | the Company promptly provides the Purchaser with prior written notice stating the Company’s intention to 
 participate in such discussions or negotiations and to provide such copies, access or disclosure;        |

| (v) | the Company enters into an Acceptable Confidentiality Agreement with such person, and the Company provides a                                                                                                                             
 copy of such agreement to the Purchaser promptly following its execution and the Purchaser is promptly provided with all information provided to such person (to the extent not previously provided to the Purchaser) via the Data Room. |

A-40

| (b) | Notwithstanding Section 6.1(a) or any other provision of this Agreement, if after the date hereof the                                                                                                                                        
 Company receives an Acquisition Proposal that constitutes a Superior Proposal, the Company may (subject to compliance with Section 8.2 and Section 8.3) terminate this Agreement and accept, approve, recommend or enter into any agreement, 
 understanding or arrangement in respect of such Superior Proposal prior to completion of the Arrangement and recommend or approve such Superior Proposal or make a Change of Recommendation, if and only if:                                 |

| (i) | such Superior Proposal did not arise, directly or indirectly, as a result of a violation by the Company of                           
 Section 6.1, and the Company has been and continues to be in compliance with its obligations under Section 6.1 and this Section 6.2; |

| (ii) | the person making the Superior Proposal was not restricted from making such Superior Proposal pursuant to an 
 existing confidentiality, standstill or similar restriction;                                                 |

| (iii) | the Board of Directors has determined in good faith, after consultation with its outside legal counsel and 
 financial advisors, that such Acquisition Proposal constitutes a Superior Proposal;                        |

| (iv) | the Company has (A) delivered written notice to the Purchaser of the determination of the Board of                                                                                                                                      
 Directors that the Acquisition Proposal is a Superior Proposal and of the intention of the Board of Directors to accept, approve, recommend or enter into an agreement in respect of such Superior Proposal (the “Superior Proposal     
 Notice”) and (B)